This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. First, let me ...

Panelists discuss how CT-155, a 16-week interactive digital application, met its primary end point in clinical trials by ...

MIAMI — Recent clinical trials on the use of herbal and nutraceutical agents as adjunctive treatment for schizophrenia show that these agents have some benefit in alleviating the negative symptoms of ...

Schizophrenia is a complex psychiatric disorder characterised by a diverse array of symptoms, with negative symptoms – such as diminished emotional expression, avolition, and anhedonia – having a ...

The study met its primary endpoint demonstrating a significant reduction in experiential negative symptoms with CT-155. For patients with schizophrenia experiencing negative symptoms, the addition of ...

Theta burst stimulation (TBS) is a non-invasive brain stimulation technique known for modifying human behavior and treating neurological diseases. A group of scientists conducted a systematic review ...

Treatment with pimavanserin failed to demonstrate a statistically significant improvement over placebo on the Negative Symptom Assessment-16 total score from baseline to week 26. Topline results were ...

Schizophrenia is a severe psychiatric disorder that can affect an individual’s ability to properly interpret reality. This disorder is characterized by “positive” and “negative” symptoms. These ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Panelists discuss how negative symptoms create significant patient burden by appearing during the prodromal period in late adolescence and requiring a comprehensive biopsychosocial treatment approach ...

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t always ...